Variant position: 22 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 533 The length of the canonical sequence.
Location on the sequence:
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human SIQVEHPAGGYKKLFETVEE LSSPLTAHVTGRIPLWLTGSL
Mouse SIQIEHPAGGYKKLFETVEE LSSPLTAHVTGRIPLWLTGSL
Rat SIQIEHPAGGYKKLFETVEE LSTPLTAHVTGRIPLWLTGSL
Bovine SSQVEHPAGGYKKLFETVEE LSSPLTAHVTGRIPLWLTGSL
Chicken YSQVEHPAGGYKKLFETVEE LSSPVTAHVTGRIPTWLRGSL
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
2 – 533 Retinoid isomerohydrolase
2 – 2 N-acetylserine
39 – 39 T -> R. Does not affect isomerohydrolase activity.
Autosomal recessive retinal dystrophy associated with two novel mutations in the RPE65 gene.
Marlhens F.; Griffoin J.-M.; Bareil C.; Arnaud B.; Claustres M.; Hamel C.P.;
Eur. J. Hum. Genet. 6:527-531(1998)
Cited for: VARIANTS LCA2 PRO-22 AND TYR-68;
Clinical and molecular genetics of Leber's congenital amaurosis: a multicenter study of Italian patients.
Simonelli F.; Ziviello C.; Testa F.; Rossi S.; Fazzi E.; Bianchi P.E.; Fossarello M.; Signorini S.; Bertone C.; Galantuomo S.; Brancati F.; Valente E.M.; Ciccodicola A.; Rinaldi E.; Auricchio A.; Banfi S.;
Invest. Ophthalmol. Vis. Sci. 48:4284-4290(2007)
Cited for: VARIANTS LCA2 PRO-22; VAL-70; PRO-91; LYS-102; ASP-144; TYR-167 AND ARG-313;
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.